ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,335.00
0.00 (0.00%)
02 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,335.00 1,333.50 1,334.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.22 55.34B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,335p. Over the last year, Gsk shares have traded in a share price range of 0.00p to 0.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £55.34 billion. Gsk has a price to earnings ratio (PE ratio) of 11.22.

Gsk Share Discussion Threads

Showing 31576 to 31599 of 34075 messages
Chat Pages: Latest  1267  1266  1265  1264  1263  1262  1261  1260  1259  1258  1257  1256  Older
DateSubjectAuthorDiscuss
09/12/2022
14:42
It is slightly amusing to think so many whizz kids in US and UK might have gotten caught short in this stock and since the courtroom results, they have to spend their entire time trying to talk it down....
I wonder what bollx they will try to come up with next.😃ԅ15;😃

netcurtains
09/12/2022
12:29
I think the message is that what's holding GSK back was never really Zantac, that's just a temporary blip thing. The real problem is their long term poor performance.
anhar
09/12/2022
08:42
Hard to swallow why markets panicked over Zantac

It’s too soon to say the great Zantac panic – the one that clobbered GlaxoSmithKline’s share price in the summer – is definitively over. Other US courts are scheduled to consider plaintiffs’ claims that a heartburn drug from the 1980s caused their cancer; and appeals can always happen. But the federal case in Florida, all sides agreed, was the big one. From the point of view of GSK and other pharma companies that had held the rights to Zantac over the decades, the verdict could not have been better.....

zho
09/12/2022
08:21
1600 starting to look like a great exit opportunity!
spoole5
08/12/2022
10:49
From a high of almost £16 yday to £14.70 now , it's the GSK rollercoaster!
alibizzle
08/12/2022
10:49
sold at 1560
when to buy back?
or maybe buy WWH instead

phillis
08/12/2022
09:38
..so, once it sinks in, it looks like it will settle around £16-£17 over the next month or two.
£18 once California court 'wins' come through.

When should we expect good news from California?

netcurtains
08/12/2022
09:37
Price drop could be due to,speculative,losing the cases still in the courts,say back to13-14 pounds.
abdullla
08/12/2022
09:34
If there was bad news about Zantac this would go down for days! With good news couldn't hold £15
mj19
08/12/2022
09:18
Speculation sells !
abdullla
07/12/2022
20:04
..so, once it sinks in, it looks like it will settle around £16-£17 over the next month or two.
£18 once California court 'wins' come through.

netcurtains
07/12/2022
19:45
Ah ok it just last night it said up $3 around 10%
alibizzle
07/12/2022
19:29
I think it's just coming off the 16 quid highs we saw over here at 8.00 am and is in line with the UK close.
stewart64
07/12/2022
19:26
Just says down 3%
alibizzle
07/12/2022
19:01
It opened adjusted for Zantac. 36.86 ÷1.22÷2= about £15.10....No?
stewart64
07/12/2022
18:35
Down 1 dollar in USA (3%) . Recovery didn't last long !
alibizzle
07/12/2022
18:19
gsk need a pipeline. Think Zantac has been masking this issue, hence to solid bounce Zantac days
Expect £14.50 or lower in the next few trading sessions

pol123
07/12/2022
17:20
GSK will sadly never have the Magic stardust attached to AZN. I don't get it...their Covid story didn't end well, the first world is totally reliant on Pfizer and Moderna. Pfizer's drugs are better imo, the NHS partially relies on Pfizer for some of the big beasts like statins. AZN trades on a p/e ten times Pfizer. Can someone cleverer than me explain why?
stewart64
07/12/2022
17:03
I want GSK to have a p/e if 50 that would be nice
mj19
07/12/2022
15:56
The Zantac claim was only ever going to get to 2 billion,about 3% of Market Cap. I guess the decision also sets a principle for future claims and indeed AZN and Pfizer have risen off the back of this.
GSK and Pfizer ( the latter is on a p/e of less than 6 for 2022) look cheap to me anyway. AZN is another story. How you can justify a p/e of 75 over the last 5 years is the biggest mystery to me in the modern history of the FTSE 100.

stewart64
07/12/2022
15:49
These were £16+ before the Zantac stuffStill a bargain long termAnd GSK is a bid target easily
mj19
07/12/2022
15:45
Great news. As the analyst note says though, this has mostly removed a negative but we also need to see positives in terms of additions to and solid progress in the pipeline.
rikky72
07/12/2022
15:34
Very happy. Well done all.
purchaseatthetop
07/12/2022
15:29
Brilliant news.
montyhedge
Chat Pages: Latest  1267  1266  1265  1264  1263  1262  1261  1260  1259  1258  1257  1256  Older

Your Recent History

Delayed Upgrade Clock